SAVAGE files Form 144 to sell 3,256 shares

SAVAGE submitted a Form 144 reporting a proposed sale of 3,256 shares of common stock of the company trading on NASDAQ, tied to an RSU vesting event dated 02/15/2026.

Rhea-AI Filing Summary

SAVAGE submitted a Form 144 reporting a proposed sale of 3,256 shares of common stock of the company trading on NASDAQ, tied to an RSU vesting event dated 02/15/2026. The filing also records 13,093 shares sold on 12/15/2025 for $1,194,372.44.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 for IRON say about the proposed sale?

It reports a proposed sale of 3,256 shares tied to RSU vesting on 02/15/2026. The filing indicates the transaction is being processed through a broker and lists the security as common stock trading on NASDAQ.

How many shares were sold recently according to the filing for IRON?

The filing records 13,093 shares sold on 12/15/2025. The reported proceeds from that sale were $1,194,372.44, as shown in the selling-activity line of the excerpt.

Who is the broker or filing agent listed on the Form 144 for IRON?

Morgan Stanley Smith Barney LLC Executive Financial Services is listed with an address at 1 New York Plaza, 8th Floor, New York, NY 10004. That broker appears in the filer information section of the excerpt.

Is the 3,256-share sale in the Form 144 an issuer sale or a brokered sale for IRON?

The excerpt links the 3,256-share entry to 'RSU Vesting' and labels the counterparty as 'Issuer', indicating the shares relate to vested restricted stock units rather than an open-market block sale.

What dates are relevant in this Form 144 filing for IRON?

Key dates shown are 02/15/2026 for the RSU vesting/proposed sale and 12/15/2025 for the prior sale of 13,093 shares. These dates are presented alongside the share amounts in the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/17/2026 - 08:51 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001951852
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	DISC MEDICINE, INC.
SEC File Number	001-39438
Address of Issuer	321 Arsenal Street Suite 101 Watertown MASSACHUSETTS 02472
Phone	617-674-9274
Name of Person for Whose Account the Securities are To Be Sold	Savage William Jacob
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	3256	182173.20	37750162	02/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/15/2026	RSU Vesting	Issuer			3256	02/15/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for WILLIAM SAVAGE 321 Arsenal Street Suite 101 Watertown MA 02472	Common	12/15/2025	13093	1194372.44

144: Remarks and Signature

Remarks	Represents sale of shares to cover tax withholding obligations in connection with the vesting of certain restricted stock units previously granted to the Reporting Person. This sale is a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
Date of Notice	02/17/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ William Savage
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)